Global Vesicular Stomatitis (VS) Therapeutics Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Vesicular stomatitis is a zoonotic viral disease that primarily affects equines, cattle and swine. The virus can also infect sheep and goats as well as wildlife.
LPI (LP Information)' newest research report, the “Vesicular Stomatitis (VS) Therapeutics Industry Forecast” looks at past sales and reviews total world Vesicular Stomatitis (VS) Therapeutics sales in 2022, providing a comprehensive analysis by region and market sector of projected Vesicular Stomatitis (VS) Therapeutics sales for 2023 through 2029. With Vesicular Stomatitis (VS) Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vesicular Stomatitis (VS) Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Vesicular Stomatitis (VS) Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vesicular Stomatitis (VS) Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vesicular Stomatitis (VS) Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vesicular Stomatitis (VS) Therapeutics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vesicular Stomatitis (VS) Therapeutics.
The global Vesicular Stomatitis (VS) Therapeutics market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Vesicular Stomatitis (VS) Therapeutics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Vesicular Stomatitis (VS) Therapeutics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Vesicular Stomatitis (VS) Therapeutics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Vesicular Stomatitis (VS) Therapeutics players cover Boehringer Ingelheim, Merck & Co, Zoetis, Vedco, Elanco, Ceva Sant? Animale, Vibrac, Vetoquinol and IDEXX Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Vesicular Stomatitis (VS) Therapeutics market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Vesicular stomatitis is a zoonotic viral disease that primarily affects equines, cattle and swine. The virus can also infect sheep and goats as well as wildlife.
LPI (LP Information)' newest research report, the “Vesicular Stomatitis (VS) Therapeutics Industry Forecast” looks at past sales and reviews total world Vesicular Stomatitis (VS) Therapeutics sales in 2022, providing a comprehensive analysis by region and market sector of projected Vesicular Stomatitis (VS) Therapeutics sales for 2023 through 2029. With Vesicular Stomatitis (VS) Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vesicular Stomatitis (VS) Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Vesicular Stomatitis (VS) Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vesicular Stomatitis (VS) Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vesicular Stomatitis (VS) Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vesicular Stomatitis (VS) Therapeutics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vesicular Stomatitis (VS) Therapeutics.
The global Vesicular Stomatitis (VS) Therapeutics market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Vesicular Stomatitis (VS) Therapeutics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Vesicular Stomatitis (VS) Therapeutics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Vesicular Stomatitis (VS) Therapeutics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Vesicular Stomatitis (VS) Therapeutics players cover Boehringer Ingelheim, Merck & Co, Zoetis, Vedco, Elanco, Ceva Sant? Animale, Vibrac, Vetoquinol and IDEXX Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Vesicular Stomatitis (VS) Therapeutics market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Symptomatic Medications
- Vaccination
- Veterinary Hospitals
- Veterinary Clinics
- Retail Pharmacies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Boehringer Ingelheim
- Merck & Co
- Zoetis
- Vedco
- Elanco
- Ceva Sant? Animale
- Vibrac
- Vetoquinol
- IDEXX Laboratories
- Covetrus
- Neogen
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vesicular Stomatitis (VS) Therapeutics Market Size 2018-2029
2.1.2 Vesicular Stomatitis (VS) Therapeutics Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Vesicular Stomatitis (VS) Therapeutics Segment by Type
2.2.1 Symptomatic Medications
2.2.2 Vaccination
2.3 Vesicular Stomatitis (VS) Therapeutics Market Size by Type
2.3.1 Vesicular Stomatitis (VS) Therapeutics Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Type (2018-2023)
2.4 Vesicular Stomatitis (VS) Therapeutics Segment by Application
2.4.1 Veterinary Hospitals
2.4.2 Veterinary Clinics
2.4.3 Retail Pharmacies
2.5 Vesicular Stomatitis (VS) Therapeutics Market Size by Application
2.5.1 Vesicular Stomatitis (VS) Therapeutics Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Application (2018-2023)
3 VESICULAR STOMATITIS (VS) THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Players
3.1.1 Global Vesicular Stomatitis (VS) Therapeutics Revenue by Players (2018-2023)
3.1.2 Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Vesicular Stomatitis (VS) Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 VESICULAR STOMATITIS (VS) THERAPEUTICS BY REGIONS
4.1 Vesicular Stomatitis (VS) Therapeutics Market Size by Regions (2018-2023)
4.2 Americas Vesicular Stomatitis (VS) Therapeutics Market Size Growth (2018-2023)
4.3 APAC Vesicular Stomatitis (VS) Therapeutics Market Size Growth (2018-2023)
4.4 Europe Vesicular Stomatitis (VS) Therapeutics Market Size Growth (2018-2023)
4.5 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2018-2023)
5.2 Americas Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2018-2023)
5.3 Americas Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vesicular Stomatitis (VS) Therapeutics Market Size by Region (2018-2023)
6.2 APAC Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2018-2023)
6.3 APAC Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Vesicular Stomatitis (VS) Therapeutics by Country (2018-2023)
7.2 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2018-2023)
7.3 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics by Region (2018-2023)
8.2 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2018-2023)
8.3 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL VESICULAR STOMATITIS (VS) THERAPEUTICS MARKET FORECAST
10.1 Global Vesicular Stomatitis (VS) Therapeutics Forecast by Regions (2024-2029)
10.1.1 Global Vesicular Stomatitis (VS) Therapeutics Forecast by Regions (2024-2029)
10.1.2 Americas Vesicular Stomatitis (VS) Therapeutics Forecast
10.1.3 APAC Vesicular Stomatitis (VS) Therapeutics Forecast
10.1.4 Europe Vesicular Stomatitis (VS) Therapeutics Forecast
10.1.5 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Forecast
10.2 Americas Vesicular Stomatitis (VS) Therapeutics Forecast by Country (2024-2029)
10.2.1 United States Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.2.2 Canada Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.2.3 Mexico Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.2.4 Brazil Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.3 APAC Vesicular Stomatitis (VS) Therapeutics Forecast by Region (2024-2029)
10.3.1 China Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.3.2 Japan Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.3.3 Korea Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.3.4 Southeast Asia Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.3.5 India Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.3.6 Australia Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.4 Europe Vesicular Stomatitis (VS) Therapeutics Forecast by Country (2024-2029)
10.4.1 Germany Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.4.2 France Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.4.3 UK Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.4.4 Italy Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.4.5 Russia Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.5 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Forecast by Region (2024-2029)
10.5.1 Egypt Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.5.2 South Africa Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.5.3 Israel Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.5.4 Turkey Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.5.5 GCC Countries Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.6 Global Vesicular Stomatitis (VS) Therapeutics Forecast by Type (2024-2029)
10.7 Global Vesicular Stomatitis (VS) Therapeutics Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Information
11.1.2 Boehringer Ingelheim Vesicular Stomatitis (VS) Therapeutics Product Offered
11.1.3 Boehringer Ingelheim Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Boehringer Ingelheim Main Business Overview
11.1.5 Boehringer Ingelheim Latest Developments
11.2 Merck & Co
11.2.1 Merck & Co Company Information
11.2.2 Merck & Co Vesicular Stomatitis (VS) Therapeutics Product Offered
11.2.3 Merck & Co Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Merck & Co Main Business Overview
11.2.5 Merck & Co Latest Developments
11.3 Zoetis
11.3.1 Zoetis Company Information
11.3.2 Zoetis Vesicular Stomatitis (VS) Therapeutics Product Offered
11.3.3 Zoetis Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Zoetis Main Business Overview
11.3.5 Zoetis Latest Developments
11.4 Vedco
11.4.1 Vedco Company Information
11.4.2 Vedco Vesicular Stomatitis (VS) Therapeutics Product Offered
11.4.3 Vedco Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Vedco Main Business Overview
11.4.5 Vedco Latest Developments
11.5 Elanco
11.5.1 Elanco Company Information
11.5.2 Elanco Vesicular Stomatitis (VS) Therapeutics Product Offered
11.5.3 Elanco Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Elanco Main Business Overview
11.5.5 Elanco Latest Developments
11.6 Ceva Sant? Animale
11.6.1 Ceva Sant? Animale Company Information
11.6.2 Ceva Sant? Animale Vesicular Stomatitis (VS) Therapeutics Product Offered
11.6.3 Ceva Sant? Animale Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Ceva Sant? Animale Main Business Overview
11.6.5 Ceva Sant? Animale Latest Developments
11.7 Vibrac
11.7.1 Vibrac Company Information
11.7.2 Vibrac Vesicular Stomatitis (VS) Therapeutics Product Offered
11.7.3 Vibrac Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Vibrac Main Business Overview
11.7.5 Vibrac Latest Developments
11.8 Vetoquinol
11.8.1 Vetoquinol Company Information
11.8.2 Vetoquinol Vesicular Stomatitis (VS) Therapeutics Product Offered
11.8.3 Vetoquinol Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Vetoquinol Main Business Overview
11.8.5 Vetoquinol Latest Developments
11.9 IDEXX Laboratories
11.9.1 IDEXX Laboratories Company Information
11.9.2 IDEXX Laboratories Vesicular Stomatitis (VS) Therapeutics Product Offered
11.9.3 IDEXX Laboratories Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 IDEXX Laboratories Main Business Overview
11.9.5 IDEXX Laboratories Latest Developments
11.10 Covetrus
11.10.1 Covetrus Company Information
11.10.2 Covetrus Vesicular Stomatitis (VS) Therapeutics Product Offered
11.10.3 Covetrus Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Covetrus Main Business Overview
11.10.5 Covetrus Latest Developments
11.11 Neogen
11.11.1 Neogen Company Information
11.11.2 Neogen Vesicular Stomatitis (VS) Therapeutics Product Offered
11.11.3 Neogen Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Neogen Main Business Overview
11.11.5 Neogen Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vesicular Stomatitis (VS) Therapeutics Market Size 2018-2029
2.1.2 Vesicular Stomatitis (VS) Therapeutics Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Vesicular Stomatitis (VS) Therapeutics Segment by Type
2.2.1 Symptomatic Medications
2.2.2 Vaccination
2.3 Vesicular Stomatitis (VS) Therapeutics Market Size by Type
2.3.1 Vesicular Stomatitis (VS) Therapeutics Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Type (2018-2023)
2.4 Vesicular Stomatitis (VS) Therapeutics Segment by Application
2.4.1 Veterinary Hospitals
2.4.2 Veterinary Clinics
2.4.3 Retail Pharmacies
2.5 Vesicular Stomatitis (VS) Therapeutics Market Size by Application
2.5.1 Vesicular Stomatitis (VS) Therapeutics Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Application (2018-2023)
3 VESICULAR STOMATITIS (VS) THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Players
3.1.1 Global Vesicular Stomatitis (VS) Therapeutics Revenue by Players (2018-2023)
3.1.2 Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Vesicular Stomatitis (VS) Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 VESICULAR STOMATITIS (VS) THERAPEUTICS BY REGIONS
4.1 Vesicular Stomatitis (VS) Therapeutics Market Size by Regions (2018-2023)
4.2 Americas Vesicular Stomatitis (VS) Therapeutics Market Size Growth (2018-2023)
4.3 APAC Vesicular Stomatitis (VS) Therapeutics Market Size Growth (2018-2023)
4.4 Europe Vesicular Stomatitis (VS) Therapeutics Market Size Growth (2018-2023)
4.5 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2018-2023)
5.2 Americas Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2018-2023)
5.3 Americas Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vesicular Stomatitis (VS) Therapeutics Market Size by Region (2018-2023)
6.2 APAC Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2018-2023)
6.3 APAC Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Vesicular Stomatitis (VS) Therapeutics by Country (2018-2023)
7.2 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2018-2023)
7.3 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics by Region (2018-2023)
8.2 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2018-2023)
8.3 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL VESICULAR STOMATITIS (VS) THERAPEUTICS MARKET FORECAST
10.1 Global Vesicular Stomatitis (VS) Therapeutics Forecast by Regions (2024-2029)
10.1.1 Global Vesicular Stomatitis (VS) Therapeutics Forecast by Regions (2024-2029)
10.1.2 Americas Vesicular Stomatitis (VS) Therapeutics Forecast
10.1.3 APAC Vesicular Stomatitis (VS) Therapeutics Forecast
10.1.4 Europe Vesicular Stomatitis (VS) Therapeutics Forecast
10.1.5 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Forecast
10.2 Americas Vesicular Stomatitis (VS) Therapeutics Forecast by Country (2024-2029)
10.2.1 United States Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.2.2 Canada Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.2.3 Mexico Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.2.4 Brazil Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.3 APAC Vesicular Stomatitis (VS) Therapeutics Forecast by Region (2024-2029)
10.3.1 China Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.3.2 Japan Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.3.3 Korea Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.3.4 Southeast Asia Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.3.5 India Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.3.6 Australia Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.4 Europe Vesicular Stomatitis (VS) Therapeutics Forecast by Country (2024-2029)
10.4.1 Germany Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.4.2 France Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.4.3 UK Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.4.4 Italy Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.4.5 Russia Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.5 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Forecast by Region (2024-2029)
10.5.1 Egypt Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.5.2 South Africa Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.5.3 Israel Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.5.4 Turkey Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.5.5 GCC Countries Vesicular Stomatitis (VS) Therapeutics Market Forecast
10.6 Global Vesicular Stomatitis (VS) Therapeutics Forecast by Type (2024-2029)
10.7 Global Vesicular Stomatitis (VS) Therapeutics Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Information
11.1.2 Boehringer Ingelheim Vesicular Stomatitis (VS) Therapeutics Product Offered
11.1.3 Boehringer Ingelheim Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Boehringer Ingelheim Main Business Overview
11.1.5 Boehringer Ingelheim Latest Developments
11.2 Merck & Co
11.2.1 Merck & Co Company Information
11.2.2 Merck & Co Vesicular Stomatitis (VS) Therapeutics Product Offered
11.2.3 Merck & Co Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Merck & Co Main Business Overview
11.2.5 Merck & Co Latest Developments
11.3 Zoetis
11.3.1 Zoetis Company Information
11.3.2 Zoetis Vesicular Stomatitis (VS) Therapeutics Product Offered
11.3.3 Zoetis Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Zoetis Main Business Overview
11.3.5 Zoetis Latest Developments
11.4 Vedco
11.4.1 Vedco Company Information
11.4.2 Vedco Vesicular Stomatitis (VS) Therapeutics Product Offered
11.4.3 Vedco Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Vedco Main Business Overview
11.4.5 Vedco Latest Developments
11.5 Elanco
11.5.1 Elanco Company Information
11.5.2 Elanco Vesicular Stomatitis (VS) Therapeutics Product Offered
11.5.3 Elanco Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Elanco Main Business Overview
11.5.5 Elanco Latest Developments
11.6 Ceva Sant? Animale
11.6.1 Ceva Sant? Animale Company Information
11.6.2 Ceva Sant? Animale Vesicular Stomatitis (VS) Therapeutics Product Offered
11.6.3 Ceva Sant? Animale Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Ceva Sant? Animale Main Business Overview
11.6.5 Ceva Sant? Animale Latest Developments
11.7 Vibrac
11.7.1 Vibrac Company Information
11.7.2 Vibrac Vesicular Stomatitis (VS) Therapeutics Product Offered
11.7.3 Vibrac Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Vibrac Main Business Overview
11.7.5 Vibrac Latest Developments
11.8 Vetoquinol
11.8.1 Vetoquinol Company Information
11.8.2 Vetoquinol Vesicular Stomatitis (VS) Therapeutics Product Offered
11.8.3 Vetoquinol Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Vetoquinol Main Business Overview
11.8.5 Vetoquinol Latest Developments
11.9 IDEXX Laboratories
11.9.1 IDEXX Laboratories Company Information
11.9.2 IDEXX Laboratories Vesicular Stomatitis (VS) Therapeutics Product Offered
11.9.3 IDEXX Laboratories Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 IDEXX Laboratories Main Business Overview
11.9.5 IDEXX Laboratories Latest Developments
11.10 Covetrus
11.10.1 Covetrus Company Information
11.10.2 Covetrus Vesicular Stomatitis (VS) Therapeutics Product Offered
11.10.3 Covetrus Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Covetrus Main Business Overview
11.10.5 Covetrus Latest Developments
11.11 Neogen
11.11.1 Neogen Company Information
11.11.2 Neogen Vesicular Stomatitis (VS) Therapeutics Product Offered
11.11.3 Neogen Vesicular Stomatitis (VS) Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Neogen Main Business Overview
11.11.5 Neogen Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Vesicular Stomatitis (VS) Therapeutics Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Symptomatic Medications
Table 3. Major Players of Vaccination
Table 4. Vesicular Stomatitis (VS) Therapeutics Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Type (2018-2023)
Table 7. Vesicular Stomatitis (VS) Therapeutics Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Application (2018-2023)
Table 10. Global Vesicular Stomatitis (VS) Therapeutics Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share by Player (2018-2023)
Table 12. Vesicular Stomatitis (VS) Therapeutics Key Players Head office and Products Offered
Table 13. Vesicular Stomatitis (VS) Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Vesicular Stomatitis (VS) Therapeutics Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Regions (2018-2023)
Table 18. Global Vesicular Stomatitis (VS) Therapeutics Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Country (2018-2023)
Table 22. Americas Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Type (2018-2023)
Table 24. Americas Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Application (2018-2023)
Table 26. APAC Vesicular Stomatitis (VS) Therapeutics Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Region (2018-2023)
Table 28. APAC Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Type (2018-2023)
Table 30. APAC Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Application (2018-2023)
Table 32. Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Country (2018-2023)
Table 34. Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Type (2018-2023)
Table 36. Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Vesicular Stomatitis (VS) Therapeutics
Table 45. Key Market Challenges & Risks of Vesicular Stomatitis (VS) Therapeutics
Table 46. Key Industry Trends of Vesicular Stomatitis (VS) Therapeutics
Table 47. Global Vesicular Stomatitis (VS) Therapeutics Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Vesicular Stomatitis (VS) Therapeutics Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Vesicular Stomatitis (VS) Therapeutics Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Boehringer Ingelheim Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 52. Boehringer Ingelheim Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 53. Boehringer Ingelheim Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Boehringer Ingelheim Main Business
Table 55. Boehringer Ingelheim Latest Developments
Table 56. Merck & Co Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 57. Merck & Co Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 58. Merck & Co Main Business
Table 59. Merck & Co Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Merck & Co Latest Developments
Table 61. Zoetis Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 62. Zoetis Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 63. Zoetis Main Business
Table 64. Zoetis Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Zoetis Latest Developments
Table 66. Vedco Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 67. Vedco Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 68. Vedco Main Business
Table 69. Vedco Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Vedco Latest Developments
Table 71. Elanco Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 72. Elanco Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 73. Elanco Main Business
Table 74. Elanco Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Elanco Latest Developments
Table 76. Ceva Sant? Animale Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 77. Ceva Sant? Animale Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 78. Ceva Sant? Animale Main Business
Table 79. Ceva Sant? Animale Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Ceva Sant? Animale Latest Developments
Table 81. Vibrac Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 82. Vibrac Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 83. Vibrac Main Business
Table 84. Vibrac Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Vibrac Latest Developments
Table 86. Vetoquinol Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 87. Vetoquinol Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 88. Vetoquinol Main Business
Table 89. Vetoquinol Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Vetoquinol Latest Developments
Table 91. IDEXX Laboratories Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 92. IDEXX Laboratories Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 93. IDEXX Laboratories Main Business
Table 94. IDEXX Laboratories Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. IDEXX Laboratories Latest Developments
Table 96. Covetrus Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 97. Covetrus Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 98. Covetrus Main Business
Table 99. Covetrus Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Covetrus Latest Developments
Table 101. Neogen Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 102. Neogen Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 103. Neogen Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Neogen Main Business
Table 105. Neogen Latest Developments
Table 1. Vesicular Stomatitis (VS) Therapeutics Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Symptomatic Medications
Table 3. Major Players of Vaccination
Table 4. Vesicular Stomatitis (VS) Therapeutics Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Type (2018-2023)
Table 7. Vesicular Stomatitis (VS) Therapeutics Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Application (2018-2023)
Table 10. Global Vesicular Stomatitis (VS) Therapeutics Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share by Player (2018-2023)
Table 12. Vesicular Stomatitis (VS) Therapeutics Key Players Head office and Products Offered
Table 13. Vesicular Stomatitis (VS) Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Vesicular Stomatitis (VS) Therapeutics Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Regions (2018-2023)
Table 18. Global Vesicular Stomatitis (VS) Therapeutics Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Country (2018-2023)
Table 22. Americas Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Type (2018-2023)
Table 24. Americas Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Application (2018-2023)
Table 26. APAC Vesicular Stomatitis (VS) Therapeutics Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Region (2018-2023)
Table 28. APAC Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Type (2018-2023)
Table 30. APAC Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Application (2018-2023)
Table 32. Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Country (2018-2023)
Table 34. Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Type (2018-2023)
Table 36. Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Vesicular Stomatitis (VS) Therapeutics
Table 45. Key Market Challenges & Risks of Vesicular Stomatitis (VS) Therapeutics
Table 46. Key Industry Trends of Vesicular Stomatitis (VS) Therapeutics
Table 47. Global Vesicular Stomatitis (VS) Therapeutics Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Vesicular Stomatitis (VS) Therapeutics Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Vesicular Stomatitis (VS) Therapeutics Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Boehringer Ingelheim Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 52. Boehringer Ingelheim Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 53. Boehringer Ingelheim Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Boehringer Ingelheim Main Business
Table 55. Boehringer Ingelheim Latest Developments
Table 56. Merck & Co Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 57. Merck & Co Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 58. Merck & Co Main Business
Table 59. Merck & Co Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Merck & Co Latest Developments
Table 61. Zoetis Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 62. Zoetis Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 63. Zoetis Main Business
Table 64. Zoetis Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Zoetis Latest Developments
Table 66. Vedco Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 67. Vedco Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 68. Vedco Main Business
Table 69. Vedco Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Vedco Latest Developments
Table 71. Elanco Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 72. Elanco Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 73. Elanco Main Business
Table 74. Elanco Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Elanco Latest Developments
Table 76. Ceva Sant? Animale Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 77. Ceva Sant? Animale Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 78. Ceva Sant? Animale Main Business
Table 79. Ceva Sant? Animale Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Ceva Sant? Animale Latest Developments
Table 81. Vibrac Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 82. Vibrac Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 83. Vibrac Main Business
Table 84. Vibrac Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Vibrac Latest Developments
Table 86. Vetoquinol Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 87. Vetoquinol Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 88. Vetoquinol Main Business
Table 89. Vetoquinol Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Vetoquinol Latest Developments
Table 91. IDEXX Laboratories Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 92. IDEXX Laboratories Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 93. IDEXX Laboratories Main Business
Table 94. IDEXX Laboratories Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. IDEXX Laboratories Latest Developments
Table 96. Covetrus Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 97. Covetrus Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 98. Covetrus Main Business
Table 99. Covetrus Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Covetrus Latest Developments
Table 101. Neogen Details, Company Type, Vesicular Stomatitis (VS) Therapeutics Area Served and Its Competitors
Table 102. Neogen Vesicular Stomatitis (VS) Therapeutics Product Offered
Table 103. Neogen Vesicular Stomatitis (VS) Therapeutics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Neogen Main Business
Table 105. Neogen Latest Developments
LIST OF FIGURES
Figure 1. Vesicular Stomatitis (VS) Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Vesicular Stomatitis (VS) Therapeutics Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Vesicular Stomatitis (VS) Therapeutics Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Vesicular Stomatitis (VS) Therapeutics Sales Market Share by Country/Region (2022)
Figure 8. Vesicular Stomatitis (VS) Therapeutics Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Type in 2022
Figure 10. Vesicular Stomatitis (VS) Therapeutics in Veterinary Hospitals
Figure 11. Global Vesicular Stomatitis (VS) Therapeutics Market: Veterinary Hospitals (2018-2023) & ($ Millions)
Figure 12. Vesicular Stomatitis (VS) Therapeutics in Veterinary Clinics
Figure 13. Global Vesicular Stomatitis (VS) Therapeutics Market: Veterinary Clinics (2018-2023) & ($ Millions)
Figure 14. Vesicular Stomatitis (VS) Therapeutics in Retail Pharmacies
Figure 15. Global Vesicular Stomatitis (VS) Therapeutics Market: Retail Pharmacies (2018-2023) & ($ Millions)
Figure 16. Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Application in 2022
Figure 17. Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share by Player in 2022
Figure 18. Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Vesicular Stomatitis (VS) Therapeutics Market Size 2018-2023 ($ Millions)
Figure 20. APAC Vesicular Stomatitis (VS) Therapeutics Market Size 2018-2023 ($ Millions)
Figure 21. Europe Vesicular Stomatitis (VS) Therapeutics Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size 2018-2023 ($ Millions)
Figure 23. Americas Vesicular Stomatitis (VS) Therapeutics Value Market Share by Country in 2022
Figure 24. United States Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Region in 2022
Figure 29. APAC Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Type in 2022
Figure 30. APAC Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Application in 2022
Figure 31. China Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Country in 2022
Figure 38. Europe Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Type (2018-2023)
Figure 39. Europe Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Application (2018-2023)
Figure 40. Germany Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 54. APAC Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 55. Europe Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 57. United States Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 58. Canada Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 61. China Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 62. Japan Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 63. Korea Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 65. India Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 66. Australia Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 67. Germany Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 68. France Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 69. UK Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 70. Italy Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 71. Russia Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 72. Spain Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 75. Israel Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 78. Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Vesicular Stomatitis (VS) Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Vesicular Stomatitis (VS) Therapeutics Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Vesicular Stomatitis (VS) Therapeutics Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Vesicular Stomatitis (VS) Therapeutics Sales Market Share by Country/Region (2022)
Figure 8. Vesicular Stomatitis (VS) Therapeutics Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Type in 2022
Figure 10. Vesicular Stomatitis (VS) Therapeutics in Veterinary Hospitals
Figure 11. Global Vesicular Stomatitis (VS) Therapeutics Market: Veterinary Hospitals (2018-2023) & ($ Millions)
Figure 12. Vesicular Stomatitis (VS) Therapeutics in Veterinary Clinics
Figure 13. Global Vesicular Stomatitis (VS) Therapeutics Market: Veterinary Clinics (2018-2023) & ($ Millions)
Figure 14. Vesicular Stomatitis (VS) Therapeutics in Retail Pharmacies
Figure 15. Global Vesicular Stomatitis (VS) Therapeutics Market: Retail Pharmacies (2018-2023) & ($ Millions)
Figure 16. Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Application in 2022
Figure 17. Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share by Player in 2022
Figure 18. Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Vesicular Stomatitis (VS) Therapeutics Market Size 2018-2023 ($ Millions)
Figure 20. APAC Vesicular Stomatitis (VS) Therapeutics Market Size 2018-2023 ($ Millions)
Figure 21. Europe Vesicular Stomatitis (VS) Therapeutics Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size 2018-2023 ($ Millions)
Figure 23. Americas Vesicular Stomatitis (VS) Therapeutics Value Market Share by Country in 2022
Figure 24. United States Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Region in 2022
Figure 29. APAC Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Type in 2022
Figure 30. APAC Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Application in 2022
Figure 31. China Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Country in 2022
Figure 38. Europe Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Type (2018-2023)
Figure 39. Europe Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Application (2018-2023)
Figure 40. Germany Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Vesicular Stomatitis (VS) Therapeutics Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 54. APAC Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 55. Europe Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 57. United States Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 58. Canada Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 61. China Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 62. Japan Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 63. Korea Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 65. India Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 66. Australia Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 67. Germany Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 68. France Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 69. UK Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 70. Italy Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 71. Russia Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 72. Spain Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 75. Israel Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Vesicular Stomatitis (VS) Therapeutics Market Size 2024-2029 ($ Millions)
Figure 78. Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Vesicular Stomatitis (VS) Therapeutics Market Size Market Share Forecast by Application (2024-2029)
